Nyxoah SA Files Routine 6-K Report
Ticker: NYXH · Form: 6-K · Filed: Nov 18, 2024 · CIK: 1857190
| Field | Detail |
|---|---|
| Company | Nyxoah SA (NYXH) |
| Form Type | 6-K |
| Filed Date | Nov 18, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer
TL;DR
Nyxoah SA filed a 6-K, standard foreign issuer report, no new info.
AI Summary
Nyxoah SA, a medical device company, filed a Form 6-K on November 18, 2024. The filing is a report of a foreign private issuer and does not contain specific financial details or significant business updates beyond its routine reporting nature.
Why It Matters
This filing indicates Nyxoah SA is fulfilling its reporting obligations as a foreign private issuer, but it does not provide new material information for investors.
Risk Assessment
Risk Level: low — The filing is a routine report of a foreign private issuer and does not contain any new material information or significant business developments.
Key Players & Entities
- Nyxoah SA (company) — Registrant
- 001-40552 (other) — Commission File Number
- 20241118 (date) — Filing Date
FAQ
What type of filing is this 6-K for Nyxoah SA?
This is a Form 6-K, a Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934.
When was this Form 6-K filed?
The filing was made on November 18, 2024.
What is Nyxoah SA's commission file number?
Nyxoah SA's commission file number is 001-40552.
Where is Nyxoah SA's principal executive office located?
Nyxoah SA's principal executive office is located at Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium.
Does this filing indicate Nyxoah SA is submitting its annual report on Form 20-F or 40-F?
The filing indicates that the registrant files or will file annual reports under cover of Form 20-F.
Filing Stats: 446 words · 2 min read · ~1 pages · Grade level 18.6 · Accepted 2024-11-18 16:42:24
Filing Documents
- tm2428713d1_6k.htm (6-K) — 11KB
- tm2428713d1_ex99-1.htm (EX-99.1) — 13KB
- tm2428713d1_ex99-1img001.jpg (GRAPHIC) — 5KB
- 0001104659-24-120168.txt ( ) — 32KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. NYXOAH SA Date: November 18, 2024 By: /s/ Olivier Taelman Name: Olivier Taelman Title: Chief Executive Officer